Cost of Goods Sold (Annual)

Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.

Elanco Animal Health Incorporated (ELAN) had Cost of Goods Sold of $2.00B for the most recently reported fiscal year, ending 2024-12-31.

Quarterly Annual

Figures for fiscal year ending 2024-12-31

Income Statement Financials
Revenue	$4.44B
Net Income	$338.00M
Cost of Goods Sold	$2.00B
Gross Profit	$2.44B
Operating Expenses	$4.34B
Operating Income	$101.00M
Non-Operating Income/Expense	$387.00M
Pre-Tax Income	$488.00M
Normalized Pre-Tax Income	$488.00M
Income after Taxes	$338.00M
Income from Continuous Operations	$338.00M
Consolidated Net Income/Loss	$338.00M
Normalized Income after Taxes	$338.00M
EBIT	$101.00M
EBITDA	$763.00M
Weighted-Average Shares Outstanding (Basic)	494.00M
Weighted-Average Shares Outstanding (Diluted)	497.30M
Earnings per Share (EPS) (Basic)	$0.68
Earnings per Share (EPS) (Diluted)	$0.68
Balance Sheet Financials
Current Assets	$3.21B
Property, Plant, and Equipment	$993.00M
Long-Term Assets	$9.40B
Total Assets	$12.61B
Current Liabilities	$1.31B
Long-Term Debt	$4.28B
Long-Term Liabilities	$5.20B
Total Liabilities	$6.52B
Common Equity	$6.10B
Tangible Shareholders Equity	$-2.00B
Shareholders Equity	$6.10B
Common Shares Outstanding	494.45M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$541.00M
Cash Flow from Investing Activities	$1.16B
Cash Flow from Financial Activities	$-1.49B
Beginning Cash	$352.00M
End Cash	$468.00M
Increase/Decrease in Cash	$116.00M
Stock-Based Compensation	$55.00M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	2.44
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.41
Debt to Equity Ratio	0.71
Gross Margin	54.88%
Operating Margin	2.28%
EBIT Margin	2.28%
EBITDA Margin	17.19%
Pre-Tax Profit Margin	10.99%
Profit Margin	7.61%
Free Cash Flow	$394.00M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.35
Inventory Turnover	1.27
Receiveable Turnover	5.01
Days Sales in Receivables	72.85
Return on Equity	5.54%
Return on Tangible Equity	-16.91%
Return on Assets	2.68%
Return on Investments	3.26%
Book Value Per Share	$12.33
Free Cash Flow per Share	$0.79
Operating Cash Flow per Share	$1.09

Data from Zacks Investment Research, Inc.